CARD16 and clostridium difficile infection: As CDI is uncommon, international collaborative research is encouraged, especially focusing on validating a convenient assay (as illustrated by the routine use of the KRYPTOR assay in humans) to allow the determination of serum CoP diagnostic cutoffs.